Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study.

Cancer Research and Treatment : Official Journal of Korean Cancer Association
Shin Hye YooDae Seog Heo

Abstract

This study aimed to investigate difficulties doctors experience during life-sustaining treatment (LST) discussion with seriously ill patients and their families after enactment of the LST Decisions Act in February 2018. A cross-sectional survey was conducted in a tertiary hospital in the Republic of Korea in August 2019. Six hundred eighty-six doctors who care for seriously ill patients were given a structured questionnaire, and difficulties during the discussion were examined. One hundred thirty-two doctors completed the questionnaire. Eighty-five percent answered they treat cancer patients. Most (86.4%) experienced considerable difficulties during LST discussions (mean score, 7.4±1.6/10). The two most common difficulties were communication with patients and family and determining when to discuss LST. Two-thirds of doctors found direct discussions with the patient difficult and said they would initiate LST discussions only with family. LST discussions were actually initiated later than considered appropriate. When medically assessing whether the patient is imminently dying, 56% of doctors experienced disagreements with other doctors, which could affect their decisions. This study found that most doctors experienced serious dif...Continue Reading

References

May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L FallowfieldA Hall
Jun 12, 1998·JAMA : the Journal of the American Medical Association·T J Smith, K Swisher
Mar 16, 2000·Journal of General Internal Medicine·R B Balaban
Sep 10, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Do-Youn OhNoe Kyeong Kim
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robin MatsuyamaThomas J Smith
Nov 8, 2007·Journal of Palliative Medicine·Do Yeun KimSoon Nam Lee
Aug 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJohn Z Ayanian
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher K Daugherty, Fay J Hlubocky
May 7, 2009·Journal of Palliative Medicine·Cori SchroderUNKNOWN Canadian Researchers at the End of Life Network
Oct 28, 2009·Academic Medicine : Journal of the Association of American Medical Colleges·Martha E BillingsRuth A Engelberg
Nov 3, 2011·Journal of Pain and Symptom Management·Elizabeth K VigRobert M Arnold
Feb 9, 2012·Annals of Internal Medicine·Jennifer W MackJane C Weeks
Jul 10, 2014·The American Journal of Hospice & Palliative Care·In Ki ParkSo Yeon Oh
Feb 18, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Younak ChoiDae Seog Heo
Oct 16, 2015·Geriatrics & Gerontology International·Dong Wook ShinJun-Hyun Yoo
Sep 3, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sun Kyung BaekDae Seog Heo
Dec 31, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Betty R FerrellThomas J Smith
Feb 13, 2017·Journal of Pain and Symptom Management·Sena YamamotoMitsunori Miyashita
Jul 5, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Su-Jin KohSun Kyung Baek
Apr 20, 2019·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ho Jung AnSu-Jin Koh
Sep 4, 2019·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hyun Jung JhoSun Young Kim
Mar 25, 2020·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jung Sun KimDae Seog Heo
Jun 1, 2019·Annals of Geriatric Medicine and Research·Ji Eun LeeUNKNOWN Korean Geriatrics Society End-of-Life Research Group

❮ Previous
Next ❯

Citations

Apr 14, 2021·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Dalyong KimChae-Man Lim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.